Centauri Therapeutics Ltd , a biotechnology company located at Discovery Park, Kent focused on the treatment of infectious diseases and cancer has been awarded up to £945,000 under Innovate UK’s Biomedical Catalyst (BMC) programme.
A former University of Warwick student has launched a ground-breaking DNA test for heart conditions that will help to save lives.
Coventry-based entrepreneur Abdullah Sabyah, who runs start-up company Rightangled, has been backed financially by NHS England through the West Midlands Academic Health Science Network (WMAHSN) and is being supported by the University of Warwick Science Park’s Business Ready programme to help bring the Heart DNA Test to market.
Pioneering research at the University of Exeter into solving the world’s energy crisis and improving energy efficiency has been presented to delegates at the first in a series of talks; The STEMM Cell @ Exeter Science Park.
A thriving innovation centre in Warwick is celebrating its 20th anniversary by taking its very high occupancy levels to the maximum.
The University of Warwick Science Park’s Warwick Innovation Centre has always enjoyed high occupancy, being between 85 per cent and as high as 99 per cent occupancy at times over the last 20 years.
Major investment sees Interface Polymers expand operations at Loughborough University Science and Enterprise Park
Interface Polymers has just closed a £2m investment round led by private capital investment group 24Haymarket to advance its unique Polarfin® copolymer additive technology.
Polarfin® additives modify the surface properties of the world’s most commonly used plastics enabling adhesion between otherwise incompatible materials.
A GOVERNMENT minister heard how the North East is leading the way in the global security and printable electronics sectors when he visited two companies at the North East Technology Park (NETPark), in County Durham.
An international leading–edge technology company has chosen Sci-Tech Daresbury as its scientific base in the UK.
Hitachi High-Technologies (Europe) is part of Japan’s Hitachi Group and is taking laboratory space in the campus’s newest building, Techspace One.
'Five Years of Innovation with Impact' highlights SBC influence on UK biotech sector
The brand new state of the art facility at the University of Wolverhampton Science Park has been officially handed over by contractors. At the beginning of August, works were concluded on the 10.1 million Science Centre which boasts Category 1 & 2 laboratories, workshops, a range of configurable office spaces and also a FabLab.
As part of the UK’s £64B life sciences sector Babraham Bioscience Technologies, (BBT), welcomes the publication of Prof. Sir John Bell’s Life Science Industrial Strategy to the UK Government.